Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes - Chen, H; Mester, T; Raychaudhuri, N; Kauh, C Y; Gupta, S; Smith, T J; Douglas, R S (J Clin Endocrinol Metab, 2014)